Prevalence of significant neoplasia in FOBT-positive patients on warfarin compared with those not on warfarin

American Journal of Gastroenterology

Volumn 105, Issue 9, 2010, Pages 2030-2034

  Iles Shih, Lulu ^a   Collins, Judy F ^a,b   Holub, Jennifer L ^a   Lieberman, David A ^a,b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b PORTLAND VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

WARFARIN; ANTICOAGULANT AGENT;

ADULT; AGED; ARTICLE; COLON CANCER; COLON POLYP; DEMOGRAPHY; DRUG USE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OCCULT BLOOD TEST; PREVALENCE; PRIORITY JOURNAL; SCREENING TEST; COLONOSCOPY; COLORECTAL NEOPLASMS; FACTUAL DATABASE; MIDDLE AGED; OCCULT BLOOD; PREDICTIVE VALUE; PROSPECTIVE STUDY; RISK; SENSITIVITY AND SPECIFICITY; STATISTICAL MODEL;

AGED; ANTICOAGULANTS; COLONOSCOPY; COLORECTAL NEOPLASMS; DATABASES, FACTUAL; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; OCCULT BLOOD; ODDS RATIO; PREDICTIVE VALUE OF TESTS; PREVALENCE; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; WARFARIN;

EID: 77956341755     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2010.264     Document Type: Article

References (33)

1. Jemal A, Siegel R, Ward E et al. Cancer statistics, 2009. CA Cancer J Clin 2009; 59: 225-249
2. Espey DK, Wu XC, Swan J et al. Annual Report to the Nationon the Status of Cancer, 1975-2004, Featuring Cancer in American Indians and Alaska Natives. Cancer 2007; 110: 2119-2152
3. Pignone M, Rich M, Teutsch SM et al. Screening for colorectal cancer in adults at average risk: a summary of the evidence for the U.S. Preventative Services Task Force. Ann Intern Med 2002; 137: 132-141
4. Mandel JS, Bond JH, Church TR et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med 1993; 328: 1365-1371
5. Levin B, Lieberman DA, McFarland B et al. Screening and Surveillance for the Early Detectionof Colorectal Cancer and Adenomatous Polyps, 2008: A Joint Guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. CA Cancer J Clin 2008; 58: 130-160
6. SmithrA, Cokkinides V, Eschenbach AC et al. American Cancer Society guidelines for the early detectionof cancer: update of early detection guidelines for prostate, colorectal and endometrial cancers. Cancer J Clin 2002; 52: 8-22
7. Winawer SJ, Fletcher RH, Rex D et al. Colorectal cancer screening and surveillance: clinical guidelines and rationale-update based on new evidence. Gastroenterology 2003; 124: 544-560
8. Allison JE. Review article: faecal occult blood testing for colorectal cancer. Aliment Pharmacol Ther 1998; 12: 1-10
9. Hemoccult Product Instructions. Beckman Coulter: Fullerton, CA, 1994
10. Sharma VK, Vasudeva R, Howden CW. Colorectal cancer screening and surveillance practices by primary care physicians: results of a national survey. Am J Gastroenterol 2000; 95: 1551-1556
11. Sharma VK, Corder FA, Fancher J et al. Survey of the opinions, knowledge, and practices of gastroenterologists regarding colorectal cancer screening and use of the fecal occult blood test. Am J Gastroenterol 2000; 95: 3629-3632
12. Sharma VK, Corder FA, Raufman JP et al. Survey of the internal medicine residents ' use of the fecal occult blood test and their understanding of colorectal cancer screening and surveillance. Am J Gastroenterol 2000; 95: 2068-2073
13. Cios DA, Baker WL, Sander SD et al. Evaluating the impact of study-level factors on warfarin control in U.S. based primary studies: a meta-analysis. Am J Health Sys Pharm 2009; 66: 916-925
14. Levin MN, Raskob G, Landefeld S et al. Hemorrhagic complications of anticoagulant treatment. Chest 2001; 119 (Suppl): 108S-21S
15. Schappert SM, Nelson C. National Ambulatory Medical Care Survey: 1995-1996 summary. Vital Health Stat 1999, i-vi, 1-122
16. Lamb E. Top 200 prescription drugs of 2007. Pharm Times 2008; (May 1) Issue 2008-05-8520
17. Bini EJ, Rajapaksa RC, Weinshel EH. Positive predictive value of fecal occult blood testing in persons taking warfarin. Am J Gastroenterol 2005; 100: 1586-1592
18. Lieberman DA, Holub JL, Moravec MD et al. Prevalence of colon polyps detected by colonoscopy screening in asymptomatic Black and White patients. JAMA 2008; 300: 1417-1422
19. Levi Z, Rozen P, Hazazi R et al. Sensitivity, but not specificity, of a quantitative immunochemical fecal occult blood test for neoplasia is slightly increased by the use of low-dose aspirin, NSAIDs, and anticoagulants. Am J Gastroenterol 2009; 104: 933-938
20. Pengo V, Pegoraro C, Cucchini U et al. Worldwide management of oral anticoagulant therapy: the ISAM study. J Thromb Thrombolysis 2006; 21: 73-77
21. Ansell J, Hirsh J, Poller L et al. The pharmacology and management of the vitamin K antagonists: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004; 126 (Suppl 3): 204S-33S
22. Gerson LB, Triadafilopoulos G, Gage BF. The management of anticoagulants in the periendoscopic period for patients with atrial fibrillation: a decision analysis. Am J Med 2004; 116: 451-459
23. Coon WW, Willis PW. Hemorrhagic complications of anticoagulant therapy. Archintern Med 1974; 133: 386-392
24. Wilcox CM, Truss CD. Gastrointestinal bleeding in patients receiving long-term anticoagulant therapy. Am J Med 1988; 84: 683-690
25. Tabibian N. Acute gastrointestinal bleeding in anticoagulated patients: a prospective evaluation. Am J Gastroenterol 1989; 84: 10-12
26. Choudari CP, Rajgopal C, Palmer KR. Acute gastrointestinal hemorrhage in anticoagulated patients: diagnoses and response to endoscopic treatment. Gut 1994; 35: 464-466
27. Choudari CP, Palmer KR. Acute gastrointestinal hemorrhage in patients treated with anticoagulant drugs. Gut 1995; 36: 483-484
28. Younossi ZM, Strum WB, Schatz RA et al. effect of combined anticoagulation and low-dose aspirin treatment on upper gastrointestinal bleeding. Dig Dis Sci 1997; 42: 79-82
29. Greenberg PD, Cello JP, Rockey DC. Asymptomatic chronic gastrointestinal blood loss in patients taking aspirinor warfarin for cardiovascular disease. Am J Med 1996; 100: 598-604
30. Prichard PJ, Kitchingman GK, Walt RP et al. Human gastric mucosal bleeding induced by low dose aspirin, but not warfarin. BMJ 1989; 298: 493-496
31. Blackshear JL, Baker VS, Holland A et al. Fecal hemoglobin excretion in elderly patients with atrial fibrillation: combined aspirin and low-dose warfarin vs. conventional warfarin therapy. Archintern Med 1996; 156: 658-660
32. Fennerty MB, Davidson J, Emerson SS et al. Are endoscopic measurements of colonic polyps reliable? Am J Gastroenterol 1992; 88: 496-500
33. Schoen RE, Gerber LD, Margulies C. The pathologic measurement of polyps size is preferable to the endoscopic estimate. Gastrointest Endosc 1997; 46: 492-496.